Caring for patients with cancer in the COVID-19 era
Joris van de Haar, Louisa Rose Hoes, Charlotte Elizabeth Coles et al. · Nature Medicine · 2020
Cited by 330 works. doi:10.1038/s41591-020-0874-8 Open-access PDF
Authors
- Joris van de Haar
- Louisa Rose Hoes
- Charlotte Elizabeth Coles
- Kenneth B. Seamon
- Stefan Fröhling
- Dirk Jäger
- Franco Valenza
- Filippo de Braud
- Luigi De Petris
- Jonas C. S. Bergh
- Ingemar T. Ernberg
- Benjamin Besse
- Fabrice Barlési
- Elena Garralda
- Alejandro Piris‐Giménez
- Michael A. Baumann
- Giovanni Apolone
- Jean‐Charles Soria
- Josep M. Tabernero
- Carlos H. Caldas
References
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- Fair Allocation of Scarce Medical Resources in the Time of Covid-19
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
- Laboratory Diagnosis and Monitoring the Viral Shedding of SARS-CoV-2 Infection
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
- Risk of COVID-19 for patients with cancer
- Risk of COVID-19 for patients with cancer
- Report 12: The global impact of COVID-19 and strategies for mitigation and suppression
- Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
- Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)